LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.
Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)
Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.
Centres to become focal points for rare disease research translation and engagement with the patient community across the UK.
The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.
Network of over 115 members works to put research at the heart of the UK’s future.
Enabling LifeArc Ventures to speak directly to fellow investors, life science companies and entrepreneurial scientists.
Takeaways from AUTM's Annual Conference for the technology transfer sector
Collaborative funding to drug discovery innovators to accelerate new treatments for people with cystic fibrosis.